At the annual meeting of the Society for Nuclear Medicine and Molecular Imaging June 6–10 in Baltimore, GE Healthcare showcased a range of hybrid molecular imaging, magnetic resonance, and nuclear medicine systems aimed at lowering dose, enhancing image quality, and increasing diagnostic accuracy. Among the technologies on display was the Discovery NM/CT 670 Pro, which combines CT technology with nuclear medicine by integrating with GE’s Optima CT540.
The Discovery system provides 50-slice equivalent CT speed along with advanced CT applications, dose management tools such as OptiDose, DoseWatch, and ASiR, and a streamlined workflow for difficult stand-alone CT procedures. The system also features GE’s Q.Suite for SPECT/CT, which includes applications such as Q.Metrix to enable quantitative accuracy and help clinicians accurately gauge a patient’s progress to optimize treatment. Q.Metrix is designed to measure and report SPECT standard uptake values in the organ or lesion of interest. The application also uses Q.AC, an image reconstruction technique designed to help improve accuracy of SPECT attenuation correction and enable quantitative SPECT measurements, even at very low CT dose.
The Discovery NM/CT 670 Pro is also available in an Adventure Series designed with pediatric patients in mind. A jungle-themed design and built-in entertainment system help relax patients and keep them occupied to encourage cooperation. Additional features such as ASiR, Q.AC, and a pediatric pallet are optimized for young patients.
In addition, GE highlighted the Signa PET/MR, what the company calls the world’s first time-of-flight-capable, integrated, simultaneous PET/MR system, and the Discovery IQ PET/CT, which cuts PET dose and scan time in half, according to the company. For more information about the company’s imaging solutions on display, visit the GE Healthcare website.
